Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
3D Systems Corp. (DDD)
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
$1.67-36.74%
Close 2026-11-05 · 1-day change
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for DDD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA loss improves to about -$4M next quarter | Profit losses are shrinking, with adjusted EBITDA improving to about -$4M. | Improving | Adjusted EBITDA loss worsens beyond -$4 million next quarter | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
DDD is a smaller-cap turnaround rather than a proven durable compounder. Its thesis is on watch: recent results show progress, but performance remains below its industry cohort and the share-price reaction has been down.
DDD is assessed as cheap versus peers, while the model has low confidence and the expectations gap is negative. The priced-in assessment is tagged justified, with low fragility; the evidence does not show that a strong recovery is already assumed.
Near term, revenue growth has been modest, though Healthcare Solutions grew about 21% in the latest comparison. Adjusted EBITDA turned positive and operating losses narrowed, but the business remains loss-making overall and the next guidance update is a key risk. Management has delivered on growth and cost priorities so far, while evidence for new product traction is limited.
Over the next few quarters, the thesis depends on continued revenue growth and cost improvement without a guidance cut. A cut would be a meaningful setback, while easing rates or steadier results from major technology peers could improve the sector backdrop. The CEO transition adds uncertainty, and the available evidence does not establish how it will affect execution.
For the 1-3 year view, DDD has measurable operating progress but still needs to prove that it can sustain growth and move beyond losses. The cheap-versus-peer assessment is balanced by elevated risk and low model confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in 3D Systems Corp.'s published investment case. The stated target is No large debt increases or equity dilution next 4 quarters. |
| Under Pressure |
| Significant new debt issuance or equity sales hurting financials |
16.4M new shares issued vs no dilution target Company sold 16.4M shares in June 2026, violating the no-dilution target despite recent earnings beats. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stable management with clear financial leadership | A supporting condition in 3D Systems Corp.'s published investment case. The stated target is No major disruptive leadership changes next 4 quarters. | Under Pressure | Unexpected major management departures or turmoil | CEO transition announced 2026-08-04 CEO retirement and succession announced; Q3 earnings beat; debt exchange routine. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $93M-$95M next quarter | 3D Systems aims to grow revenue near $95M next quarter. | Intact | Revenue falls below $93 million next quarter | Revenue: $99.304M FY2026-Q3; GAAP. Published target: >= $93 million. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 4, 202699,304,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.13 → $-0.13 · observed estimates
$0.41B → $0.41B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-07-25 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-07-26 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-07-27 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-07-28 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-07-29 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-07-30 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-07-31 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-08-01 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-08-02 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-08-03 | $-0.13 | $405,785,500 | 4 / 4 |
| 2026-08-04 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-08-05 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-08-06 | $-0.13 | $405,785,500 | 2 / 3 |
| 2026-08-07 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-08 | $-0.14 | $408,833,500 | 4 / 4 |
| 2026-08-09 | $-0.14 | $408,833,500 | 4 / 4 |
| 2026-08-10 | $-0.14 | $408,833,500 | 4 / 4 |
| 2026-08-11 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-12 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-13 | $-0.14 | $408,833,500 | 4 / 4 |
| 2026-08-14 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-15 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-16 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-17 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-18 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-19 | $-0.14 | $408,833,500 | 2 / 3 |
| 2026-08-20 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-21 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-22 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-23 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-24 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-25 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-26 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-27 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-28 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-29 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-30 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-08-31 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-01 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-02 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-03 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-04 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-05 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-06 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-07 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-08 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-09 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-10 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-11 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-12 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-13 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-14 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-15 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-16 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-17 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-18 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-19 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-20 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-21 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-22 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-23 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-24 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-25 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-26 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-27 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-28 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-29 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-09-30 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-01 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-02 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-03 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-04 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-05 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-06 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-07 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-08 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-09 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-10 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-11 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-12 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-13 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-14 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-15 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-16 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-17 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-18 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-19 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-20 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-21 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-22 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-23 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-24 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-25 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-26 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-27 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-28 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-29 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-30 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-10-31 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-11-01 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-11-02 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-11-03 | $-0.13 | $410,497,250 | 2 / 3 |
| 2026-11-04 | $-0.13 | $410,497,250 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.